← 產業報告目錄
Targeted Protein Degradation Market Share & Trends Analysis Report, Distribution by Type of Degrader (SERD, PROTAC and Molecular Glue), Target Indication (Breast Cancer and Multiple Myeloma), By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-13頁數 180報告編號 INSIGHTACE-a11a6b9118
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Targeted Protein Degradation Market stood at USD 0.5 Billion in 2024, and is projected to reach USD 5.5 Billion by 2034, recording a CAGR of 26.6% from 2025 through 2034.
The Targeted Protein Degradation sector involves a novel therapeutic strategy that harnesses the cell's natural protein disposal system to eliminate unwanted proteins. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Targeted Protein Degradation Market Snapshot
Chapter 4. Global Targeted Protein Degradation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Degrader Estimates & Trend Analysis
5.1. by Type of Degrader & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Degrader:
5.2.1. SERD
5.2.2. PROTAC
5.2.3. Molecular Glue
Chapter 6. Market Segmentation 2: by Target Indication Estimates & Trend Analysis
6.1. by Target Indication & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Indication:
6.2.1. Breast Cancer
6.2.2. Myeloma
Chapter 7. Targeted Protein Degradation Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.1.2. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.1.3. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.2.2. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.2.3. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.3.2. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.3.3. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.4.2. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.4.3. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.5.2. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.5.3. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Arvinas
8.2.2. Bristol-Myers Squibb
8.2.3. C4 Therapeutics
8.2.4. Loxo Oncology
8.2.5. Olema Oncology
8.2.6. Radius Health
8.2.7. AstraZeneca
8.2.8. Roche
8.2.9. BeiGene
8.2.10. InnoCare Pharma
8.2.11. Kangpu Biopharmaceuticals
8.2.12. Kintor Pharmaceuticals
8.2.13. Medivir
8.2.14. Monte Rosa Therapeutics
8.2.15. Ranok Therapeutics
8.2.16. Sanofi
8.2.17. Zentalis Pharmaceuticals
8.2.18. Eisai Therapeutics
8.2.19. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們